Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Beta-lactam and Beta-lactamase Inhibitors market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for Beta-lactam and Beta-lactamase Inhibitors are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Beta-lactam and Beta-lactamase Inhibitors market segmented into
Penicillin
Cephalosporin
Carbapenem
Monobactam
Combination

Based on the end-use, the global Beta-lactam and Beta-lactamase Inhibitors market classified into
Oral
Intravenous
Others

Based on geography, the global Beta-lactam and Beta-lactamase Inhibitors market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Abbott Laboratories
Allergan Plc.
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
Merck & Co. Inc.
Mylan N.V.
Novartis International AG (Sandoz)
Pfizer Inc.
Sanofi
Teva Pharmaceutical Industries Ltd

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL BETA-LACTAM AND BETA-LACTAMASE INHIBITORS INDUSTRY
2.1 Summary about Beta-lactam and Beta-lactamase Inhibitors Industry
2.2 Beta-lactam and Beta-lactamase Inhibitors Market Trends
2.2.1 Beta-lactam and Beta-lactamase Inhibitors Production & Consumption Trends
2.2.2 Beta-lactam and Beta-lactamase Inhibitors Demand Structure Trends
2.3 Beta-lactam and Beta-lactamase Inhibitors Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Penicillin
4.2.2 Cephalosporin
4.2.3 Carbapenem
4.2.4 Monobactam
4.2.5 Combination
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Oral
4.3.2 Intravenous
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Penicillin
5.2.2 Cephalosporin
5.2.3 Carbapenem
5.2.4 Monobactam
5.2.5 Combination
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Oral
5.3.2 Intravenous
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Penicillin
6.2.2 Cephalosporin
6.2.3 Carbapenem
6.2.4 Monobactam
6.2.5 Combination
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Oral
6.3.2 Intravenous
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Penicillin
7.2.2 Cephalosporin
7.2.3 Carbapenem
7.2.4 Monobactam
7.2.5 Combination
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Oral
7.3.2 Intravenous
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Penicillin
8.2.2 Cephalosporin
8.2.3 Carbapenem
8.2.4 Monobactam
8.2.5 Combination
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Oral
8.3.2 Intravenous
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Penicillin
9.2.2 Cephalosporin
9.2.3 Carbapenem
9.2.4 Monobactam
9.2.5 Combination
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Oral
9.3.2 Intravenous
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Abbott Laboratories
10.1.2 Allergan Plc.
10.1.3 F. Hoffmann-La Roche Ltd.
10.1.4 GlaxoSmithKline plc
10.1.5 Merck & Co. Inc.
10.1.6 Mylan N.V.
10.1.7 Novartis International AG (Sandoz)
10.1.8 Pfizer Inc.
10.1.9 Sanofi
10.1.10 Teva Pharmaceutical Industries Ltd
10.2 Beta-lactam and Beta-lactamase Inhibitors Sales Date of Major Players (2017-2020e)
10.2.1 Abbott Laboratories
10.2.2 Allergan Plc.
10.2.3 F. Hoffmann-La Roche Ltd.
10.2.4 GlaxoSmithKline plc
10.2.5 Merck & Co. Inc.
10.2.6 Mylan N.V.
10.2.7 Novartis International AG (Sandoz)
10.2.8 Pfizer Inc.
10.2.9 Sanofi
10.2.10 Teva Pharmaceutical Industries Ltd
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT


List of Table
1.Table Beta-lactam and Beta-lactamase Inhibitors Product Type Overview
2.Table Beta-lactam and Beta-lactamase Inhibitors Product Type Market Share List
3.Table Beta-lactam and Beta-lactamase Inhibitors Product Type of Major Players
4.Table Brief Introduction of Abbott Laboratories
5.Table Brief Introduction of Allergan Plc.
6.Table Brief Introduction of F. Hoffmann-La Roche Ltd.
7.Table Brief Introduction of GlaxoSmithKline plc
8.Table Brief Introduction of Merck & Co. Inc.
9.Table Brief Introduction of Mylan N.V.
10.Table Brief Introduction of Novartis International AG (Sandoz)
11.Table Brief Introduction of Pfizer Inc.
12.Table Brief Introduction of Sanofi
13.Table Brief Introduction of Teva Pharmaceutical Industries Ltd
14.Table Products & Services of Abbott Laboratories
15.Table Products & Services of Allergan Plc.
16.Table Products & Services of F. Hoffmann-La Roche Ltd.
17.Table Products & Services of GlaxoSmithKline plc
18.Table Products & Services of Merck & Co. Inc.
19.Table Products & Services of Mylan N.V.
20.Table Products & Services of Novartis International AG (Sandoz)
21.Table Products & Services of Pfizer Inc.
22.Table Products & Services of Sanofi
23.Table Products & Services of Teva Pharmaceutical Industries Ltd
24.Table Market Distribution of Major Players
25.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
26.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
27.Table Global Beta-lactam and Beta-lactamase Inhibitors Market Forecast (Million USD) by Region 2021f-2026f
28.Table Global Beta-lactam and Beta-lactamase Inhibitors Market Forecast (Million USD) Share by Region 2021f-2026f
29.Table Global Beta-lactam and Beta-lactamase Inhibitors Market Forecast (Million USD) by Demand 2021f-2026f
30.Table Global Beta-lactam and Beta-lactamase Inhibitors Market Forecast (Million USD) Share by Demand 2021f-2026f

List of Figure
1.Figure Global Beta-lactam and Beta-lactamase Inhibitors Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Beta-lactam and Beta-lactamase Inhibitors Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Beta-lactam and Beta-lactamase Inhibitors Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Beta-lactam and Beta-lactamase Inhibitors Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Beta-lactam and Beta-lactamase Inhibitors Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Beta-lactam and Beta-lactamase Inhibitors Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Beta-lactam and Beta-lactamase Inhibitors Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Penicillin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Cephalosporin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Carbapenem Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Monobactam Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Combination Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Intravenous Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Penicillin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Cephalosporin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Carbapenem Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Monobactam Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Combination Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Intravenous Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Penicillin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Cephalosporin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Carbapenem Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Monobactam Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Combination Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Intravenous Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Penicillin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Cephalosporin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Carbapenem Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Monobactam Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Combination Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Intravenous Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Penicillin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Cephalosporin Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Carbapenem Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Monobactam Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Combination Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Oral Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Intravenous Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
72.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
73.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
74.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY)

Global Irritable Bowel Disease Market (2024 Edition): Analysis By Drug Class (Corticosteroids, JAK inhibitors, TNF inhibitors, Other Drug Classes), By Route of Administration, By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)...

Executive Summary Azoth Analytics has released a research report titled "Global Irritable Bowel Disease Market (2024 Edition)" which provides a complete analysis of the Global Irritable Bowel Disease industry in terms of market segmentation By Drug Class (Corticosteroids, JAK inhibitors...

Global Incretin Based Drugs Market (2023 Edition): Analysis By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4 Inhibitors), Route of Administration, By Indication, By Region, By Country: Market Insights and Forecast (2019-2029) ...

Executive Summary Azoth Analytics has released a research report titled "Incretin Based Drugs Market (2023 Edition)" which provides a complete analysis of the global Incretin Based Drugs industry in terms of market segmentation By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Di...

2023-2028 Global and Regional Oilfield Shale Inhibitors Industry Status and Prospects Professional Market Research Report Standard Version...

The global Oilfield Shale Inhibitors market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in...

2023-2028 Global and Regional Shale Inhibitors Industry Status and Prospects Professional Market Research Report Standard Version...

The global Shale Inhibitors market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this fie...

2023-2028 Global and Regional Beta-Eudesmol Industry Status and Prospects Professional Market Research Report Standard Version...

The global Beta-Eudesmol market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field ...

2023-2028 Global and Regional Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Status and Prospects Professional Market Research Report Standard Version...

The global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help m...

2023-2028 Global and Regional Interleukin Inhibitors Industry Status and Prospects Professional Market Research Report Standard Version...

The global Interleukin Inhibitors market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in th...

2023-2028 Global and Regional Beta-Cyclodextrin Industry Status and Prospects Professional Market Research Report Standard Version...

The global Beta-Cyclodextrin market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this fi...

2023-2028 Global and Regional Mircera (methoxy polyethylene glycol-epoetin beta) Industry Status and Prospects Professional Market Research Report Standard Version...

The global Mircera (methoxy polyethylene glycol-epoetin beta) market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which wi...

2023-2028 Global and Regional Non-Tyrosine Kinase Inhibitors Industry Status and Prospects Professional Market Research Report Standard Version...

The global Non-Tyrosine Kinase Inhibitors market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market playe...